Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review

Harold M. P. Pelikan*, J. W. Trum, F. C. H. Bakers, R. G. H. Beets-Tan, L. J. M. Smits, R. F. P. M. Kruitwagen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Background: Approximately 72% of endometrial cancers are FIGO stage I at diagnosis and about 10% have lymph node metastases. An ideal diagnostic test for nodal disease would be able to prevent both overtreatment (i.e. unnecessary lymphadenectomy) and undertreatment (i.e. withholding lymphadenectomy or adjuvant postoperative treatment to patients with lymph node metastases). Objectives: In this review we compare the accuracy of preoperative tests (computed tomography, magnetic resonance imaging, positron emission tomography-computed tomography, CA-125 serum levels, and ultrasonography) for the detection of lymph node metastases in endometrial cancers with the final histopathologic diagnosis after complete pelvic and para-aortic lymphadenectomy as the gold standard. Method: A systematic search in MEDLINE (using PubMed), Embase and The Cochrane Library was performed up to 23 July 2012. Results: We found one article that met our inclusion criteria for computed tomography, none for magnetic resonance imaging, 2 for positron emission tomography/computed tomography), 2 for CA-125 and none for ultrasonography. Conclusions: Due to the lack of high-quality articles on a preoperative test for lymph node status in endometrial cancer, no proper comparison between these modalities can be made.
Original languageEnglish
Pages (from-to)314-322
JournalCancer Imaging
Issue number3
Publication statusPublished - 2013


  • Endometrial cancer
  • lymph nodes
  • diagnosis
  • staging
  • lymphadenectomy
  • test


Dive into the research topics of 'Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review'. Together they form a unique fingerprint.

Cite this